West to Present at Investor Conference
* Reuters is not responsible for the content in this press release.
LIONVILLE, Pa., Nov. 12 /PRNewswire-FirstCall/ -- West Pharmaceutical
Services, Inc. (NYSE: WST) today announced that Donald E. Morel, Jr., Ph.D.,
Chairman and Chief Executive Officer, and William Federici, Chief Financial
Officer, will attend the Lazard Capital Markets 6th Annual Healthcare
Conference in New York, NY, and will present an overview of West's business
and outlook on Tuesday, November 17, 2009 at 1:40 PM ET.
A copy of the corporate presentation document as well as a live audio webcast
of the presentations will be posted on the investor link of the Company's
website at www.westpharma.com.
About West
West is a global manufacturer of components and systems for injectable drug
delivery, including stoppers and seals for vials, and closures and disposable
components used in syringe, IV and blood collection systems. The Company also
provides products with application to the personal care, food and beverage
markets. Headquartered in Lionville, Pennsylvania, West supports its partners
and customers from 50 locations throughout North America, South America,
Europe, Mexico, Japan, Asia and Australia. For more information, visit West at
www.westpharma.com.
Contacts:
West Pharmaceutical Services, Inc. Investors and Financial Media:
Michael A. Anderson Westwicke Partners
Vice President and Treasurer John Woolford/Stefan Loren
(610) 594-3345 (443) 213-0506/0507
SOURCE West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc., Michael A. Anderson, Vice President and
Treasurer, +1-610-594-3345; or Investors and Financial Media, Westwicke
Partners, John Woolford, +1-443-213-0506, or Stefan Loren, +1-443-213-0507
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters